A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer
Stuart J. Schnitt(Brigham and Women's Hospital), Jay R. Harris(Harvard University), James A. Hayman(University of Michigan), Susan K. Pierce(National Institute of Allergy and Infectious Diseases), Timothy J. Eberlein, Patti Cohen(Harvard University), Rebecca Gelman(Dana-Farber Cancer Institute), Susan M. Love(University of California, Los Angeles), Barbara Silver(Harvard University), Lindsey Schneider(Harvard University), Asa J. Nixon(Dana-Farber Brigham Cancer Center), Kathleen Mayzel(Brigham and Women's Faulkner Hospital), Robert T. Osteen(John Brown University), James L. Connolly(Beth Israel Deaconess Medical Center), Abram Recht(Beth Israel Deaconess Medical Center)
Cited by 12
Related Papers
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k
Molecular characterization of the tumor microenvironment in breast cancer
|Cancer Cell|2004|1.3k
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
|Journal of Clinical Oncology|2002|1.2k
Prognostic Factors in Breast Cancer
|Archives of Pathology & Laboratory Medicine|2000|1.1k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k